-
1
-
-
27144498992
-
Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries
-
Tulis DA, Keswani AN, Peyton KJ, et al. Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries. Cell Mol Biol. 2005;51:441-446.
-
(2005)
Cell Mol Biol
, vol.51
, pp. 441-446
-
-
Tulis, D.A.1
Keswani, A.N.2
Peyton, K.J.3
-
2
-
-
33644828772
-
Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation
-
DOI 10.1161/01.ATV.0000191635.00744.b6, PII 0004360520060100000015
-
Yang X, Thomas DP, Zhang X, et al. Curcumin inhibits PDGF-stimulated vascular smooth muscle cell function and injury-induced neointima formation. Arterioscler Thromb Vasc Biol. 2006;26:85-90. (Pubitemid 43732232)
-
(2006)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.26
, Issue.1
, pp. 85-90
-
-
Yang, X.1
Thomas, D.P.2
Zhang, X.3
Culver, B.W.4
Alexander, B.M.5
Murdoch, W.J.6
Rao, M.N.A.7
Tulis, D.A.8
Ren, J.9
Sreejayan, N.10
-
3
-
-
0034595296
-
Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1) and p16(Ink4) on vascular smooth muscle cell proliferation
-
Tanner FC, Boehm M, Akyurek LM, et al. Differential effects of the cyclin-dependent kinase inhibitors p27Kip1, p21Cip1, and p16Ink4 on vascular smooth muscle cell proliferation. Circulation. 2000;101: 2022-2025. (Pubitemid 30233162)
-
(2000)
Circulation
, vol.101
, Issue.17
, pp. 2022-2025
-
-
Tanner, F.C.1
Boehm, M.2
Akyurek, L.M.3
San, H.4
Yang, Z.-Y.5
Tashiro, J.6
Nabel, G.J.7
Nabel, E.G.8
-
4
-
-
33748967935
-
Honokiol causes the p21Waf1-mediated G(1)- Phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells
-
Lee B, Kim CH, Moon SK. Honokiol causes the p21Waf1-mediated G(1)- phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells. FEBS Lett. 2006;580: 5177-5184.
-
(2006)
FEBS Lett
, vol.580
, pp. 5177-5184
-
-
Lee, B.1
Kim, C.H.2
Moon, S.K.3
-
5
-
-
46449129215
-
Hesperetin, a bioflavonoid, inhibits rat aortic vascular smooth muscle cells proliferation by arresting cell cycle
-
Jin YR, Han XH, Zhang YH, et al. Hesperetin, a bioflavonoid, inhibits rat aortic vascular smooth muscle cells proliferation by arresting cell cycle. J Cell Biochem. 2007;104:1-14.
-
(2007)
J Cell Biochem
, vol.104
, pp. 1-14
-
-
Jin, Y.R.1
Han, X.H.2
Zhang, Y.H.3
-
6
-
-
34247154034
-
Pharmacologic modulators of soluble guanylate cyclase/cyclic guanosine monophosphate in the vascular system-from benchtop to bedside
-
Jackson E, Mukhopadhyay S, Tulis DA. Pharmacologic modulators of soluble guanylate cyclase/cyclic guanosine monophosphate in the vascular system-from benchtop to bedside. Curr Vasc Pharmacol. 2007;5:1-14.
-
(2007)
Curr Vasc Pharmacol
, vol.5
, pp. 1-14
-
-
Jackson, E.1
Mukhopadhyay, S.2
Tulis, D.A.3
-
7
-
-
0035960644
-
Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation
-
Tulis DA, Durante W, Liu XM, et al. Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation. 2001;104:2710-2715. (Pubitemid 33108139)
-
(2001)
Circulation
, vol.104
, Issue.22
, pp. 2710-2715
-
-
Tulis, D.A.1
Durante, W.2
Liu, X.3
Evans, A.J.4
Peyton, K.J.5
Schafer, A.I.6
-
8
-
-
0035112603
-
Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries
-
DOI 10.1016/S0021-9150(00)00552-9, PII S0021915000005529
-
Tulis DA, Durante W, Peyton KJ, et al. Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries. Atherosclerosis. 2001;155:113-122. (Pubitemid 32167130)
-
(2001)
Atherosclerosis
, vol.155
, Issue.1
, pp. 113-122
-
-
Tulis, D.A.1
Durante, W.2
Peyton, K.J.3
Evans, A.J.4
Schafer, A.I.5
-
9
-
-
57649133965
-
Novel therapies for cyclic GMP control of vascular smooth muscle growth
-
In press
-
Tulis DA. Novel therapies for cyclic GMP control of vascular smooth muscle growth. Am J Ther. 2008. In press.
-
(2008)
Am J Ther
-
-
Tulis, D.A.1
-
10
-
-
33748312096
-
NO-independent stimulators and activators of soluble guanylate cyclase: Discovery and therapeutic potential
-
DOI 10.1038/nrd2038, PII NRD2038
-
Evgenov OV, Pacher P, Schmidt PM, et al. NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov. 2006;5:755-768. (Pubitemid 44323702)
-
(2006)
Nature Reviews Drug Discovery
, vol.5
, Issue.9
, pp. 755-768
-
-
Evgenov, O.V.1
Pacher, P.2
Schmidt, P.M.3
Hasko, G.4
Schmidt, H.H.H.W.5
Stasch, J.-P.6
-
11
-
-
0034694942
-
YC-1, a benzyl indazole derivative, stimulates vascular cGMP and inhibits neointima formation
-
Tulis DA, DuranteW, Peyton KJ, et al. YC-1, a benzyl indazole derivative, stimulates vascular cGMP and inhibits neointima formation. Biochem Biophys Res Commun. 2000;279:646-652.
-
(2000)
Biochem Biophys Res Commun
, vol.279
, pp. 646-652
-
-
Tulis, D.A.1
Durante, W.2
Peyton, K.J.3
-
12
-
-
0036296770
-
YC-1-mediated vascular protection through inhibition of smooth muscle cell proliferation and platelet function
-
DOI 10.1006/bbrc.2002.6552
-
Tulis DA, Bohl Masters KS, Lipke EA, et al. YC-1-mediated vascular protection through inhibition of smooth muscle cell proliferation and platelet function. Biochem Biophys Res Commun. 2002;291:1014-1021. (Pubitemid 34694377)
-
(2002)
Biochemical and Biophysical Research Communications
, vol.291
, Issue.4
, pp. 1014-1021
-
-
Tulis, D.A.1
Bohl Masters, K.S.2
Lipke, E.A.3
Schiesser, R.L.4
Evans, A.J.5
Peyton, K.J.6
Durante, W.7
West, J.L.8
Schafer, A.I.9
-
13
-
-
4444348385
-
Salutary properties of YC-1 in the cardiovascular and hematological systems
-
Tulis DA. Salutary properties of YC-1 in the cardiovascular and hematological systems. Curr Med Chem Cardiovasc Hematol Agents. 2004;2:343-359.
-
(2004)
Curr Med Chem Cardiovasc Hematol Agents
, vol.2
, pp. 343-359
-
-
Tulis, D.A.1
-
14
-
-
29244492264
-
YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1- Benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9
-
Liu YN, Pan SL, Peng CY, et al. YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1- benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9. J Pharmacol Exp Ther. 2006;316:35-41.
-
(2006)
J Pharmacol Exp Ther
, vol.316
, pp. 35-41
-
-
Liu, Y.N.1
Pan, S.L.2
Peng, C.Y.3
-
15
-
-
0035826261
-
NO-independent regulatory site on soluble guanylate cyclase
-
DOI 10.1038/35065611
-
Stasch JP, Becker EM, Alonso-Alija C, et al. NO-independent regulatory site on soluble guanylate cyclase. Nature. 2001;410:212-215. (Pubitemid 32216593)
-
(2001)
Nature
, vol.410
, Issue.6825
, pp. 212-215
-
-
Stasch, J.-P.1
Becker, E.M.2
Alonso-Alija, C.3
Apeler, H.4
Dembowsky, K.5
Feurer, A.6
Gerzer, R.7
Minuth, T.8
Perzborn, E.9
Pleiss, U.10
Schroder, H.11
Schroeder, W.12
Stahl, E.13
Steinke, W.14
Straub, A.15
Schramm, M.16
-
16
-
-
0035987790
-
NO- And haem-independent activation of soluble guanylyl cyclase: Molecular basis and cardiovascular implications of a new pharmacological principle
-
Stasch JP, Schmidt P, Alonso-Alija C, et al. NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle. Br J Pharmacol. 2002; 136:773-783.
-
(2002)
Br J Pharmacol
, vol.136
, pp. 773-783
-
-
Stasch, J.P.1
Schmidt, P.2
Alonso-Alija, C.3
-
17
-
-
34247282009
-
Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease
-
DOI 10.1111/j.1527-3466.2007.00003.x
-
Boerrigter G, Burnett JC. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease. Cardiovasc Drug Rev. 2007;25:30-45. (Pubitemid 46625289)
-
(2007)
Cardiovascular Drug Reviews
, vol.25
, Issue.1
, pp. 30-45
-
-
Boerrigter, G.1
Burnett Jr., J.C.2
-
18
-
-
33745699566
-
Protective effects of BAY 41-2272 (sGC stimulator) on hypertension, heart, and cardiomyocyte hypertrophy induced by chronic L-NAME treatment in rats
-
DOI fjc.0000210071.54828.9b, PII 0000534420060300000009
-
Zanfolin M, Faro R, Araujo EG, et al. Protective effects of BAY 41-2272 (sGC stimulator) on hypertension, heart, and cardiomyocyte hypertrophy induced by chronic L-NAME treatment in rats. J Cardiovasc Pharmacol. 2006;47:391-395. (Pubitemid 44309692)
-
(2006)
Journal of Cardiovascular Pharmacology
, vol.47
, Issue.3
, pp. 391-395
-
-
Zanfolin, M.1
Faro, R.2
Araujo, E.G.3
Guaraldo, A.M.A.4
Antunes, E.5
Nucci, G.D.6
-
19
-
-
0042334864
-
Antiplatelet properties of a novel, non-NO-based soluble guanylate cyclase activator, BAY 41-2272
-
DOI 10.1016/S1537-1891(03)00046-6
-
Hobbs AJ, Moncada S. Antiplatelet properties of a novel, non-NO-based soluble guanylate cyclase activator, BAY 41-2272. Vascul Pharmacol. 2003;40:149-154. (Pubitemid 37103081)
-
(2003)
Vascular Pharmacology
, vol.40
, Issue.3
, pp. 149-154
-
-
Hobbs, A.J.1
Moncada, S.2
-
20
-
-
0037432180
-
Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure
-
DOI 10.1161/01.CIR.0000055737.15443.F8
-
Boerrigter G, Costello-Boerrigter LC, Cataliotti A, et al. Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure. Circulation. 2003; 107:686-689. (Pubitemid 36222594)
-
(2003)
Circulation
, vol.107
, Issue.5
, pp. 686-689
-
-
Boerrigter, G.1
Costello-Boerrigter, L.C.2
Cataliotti, A.3
Tsuruda, T.4
Harty, G.J.5
Lapp, H.6
Stasch, J.-P.7
Burnett, J.C.8
-
21
-
-
0035427561
-
Sensitive determination of cell number using the CyQUANT cell proliferation assay
-
DOI 10.1016/S0022-1759(01)00404-5, PII S0022175901004045
-
Jones LJ, Gray M, Yue ST, et al. Sensitive determination of cell number using the CyQUANT cell proliferation assay. J Immunol Methods. 2001; 254:85-98. (Pubitemid 32530750)
-
(2001)
Journal of Immunological Methods
, vol.254
, Issue.1-2
, pp. 85-98
-
-
Jones, L.J.1
Gray, M.2
Yue, S.T.3
Haugland, R.P.4
Singer, V.L.5
-
22
-
-
0028945134
-
Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide
-
Christodoulides N, Durante W, Kroll MH, et al. Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation. 1995;91:2306-2309.
-
(1995)
Circulation
, vol.91
, pp. 2306-2309
-
-
Christodoulides, N.1
Durante, W.2
Kroll, M.H.3
-
23
-
-
0032725611
-
Platelet-derived growth factor stimulates heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells
-
Durante W, Peyton KJ, Schafer AI. Platelet-derived growth factor stimulates heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999;19:2666-2672. (Pubitemid 29536041)
-
(1999)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.19
, Issue.11
, pp. 2666-2672
-
-
Durante, W.1
Peyton, K.J.2
Schafer, A.I.3
-
24
-
-
0026040162
-
Differences in response between SHRSP andWKY vascular smooth muscle cells to inhibition of cell proliferation by sodium nitroprusside
-
Shimizu S, Nara Y, Yamori Y, et al. Differences in response between SHRSP andWKY vascular smooth muscle cells to inhibition of cell proliferation by sodium nitroprusside. Clin Exp Hypertens A. 1991;13:787-795.
-
(1991)
Clin Exp Hypertens a
, vol.13
, pp. 787-795
-
-
Shimizu, S.1
Nara, Y.2
Yamori, Y.3
-
25
-
-
0032535947
-
Nitric oxide inhibits Oct-1 DNA binding activity in cultured vascular smooth muscle cells
-
Liu XK, Abernethy DR, Andrawis NS. Nitric oxide inhibits Oct-1 DNA binding activity in cultured vascular smooth muscle cells. Life Sci. 1998; 62:739-749.
-
(1998)
Life Sci
, vol.62
, pp. 739-749
-
-
Liu, X.K.1
Abernethy, D.R.2
Andrawis, N.S.3
-
26
-
-
0004285343
-
-
New York, NY: McGraw Hill Medical Publishing Division
-
Glantz SA. Primer of Biostatistics. 6th ed. New York, NY: McGraw Hill Medical Publishing Division; 2005.
-
(2005)
Primer of Biostatistics. 6th Ed
-
-
Glantz, S.A.1
-
27
-
-
3943087022
-
Vasodilator-stimulated phosphoprotein regulates proliferation and growth inhibition by nitric oxide in vascular smooth muscle cells
-
DOI 10.1161/01.ATV.0000134705.39654.53
-
Chen L, Daum G, Chitaley K, et al. Vasodilator-stimulated phosphoprotein regulates proliferation and growth inhibition by nitric oxide in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2004;24: 1403-1408. (Pubitemid 39050432)
-
(2004)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.24
, Issue.8
, pp. 1403-1408
-
-
Chen, L.1
Daum, G.2
Chitaley, K.3
Coats, S.A.4
Bowen-Pope, D.F.5
Eigenthaler, M.6
Thumati, N.R.7
Walter, U.8
Clowes, A.W.9
-
29
-
-
0025250142
-
Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP- And cAMP-elevating vasodilators
-
Halbrugge M, Friedrich C, Eigenthaler M, et al. Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators. J Biol Chem. 1990; 265:3088-3093. (Pubitemid 20087285)
-
(1990)
Journal of Biological Chemistry
, vol.265
, Issue.6
, pp. 3088-3093
-
-
Halbrugge, M.1
Friedrich, C.2
Eigenthaler, M.3
Schanzenbacher, P.4
Walter, U.5
-
30
-
-
0026315448
-
Endothelial cell-dependent phosphorylation of a platelet protein mediated by cAMP- And cGMP-elevating factors
-
Nolte C, Eigenthaler M, Schanzenbacher P, et al. Endothelial celldependent phosphorylation of a platelet protein mediated by cAMP- and cGMP-elevating agents. J Biol Chem. 1991;266:14808-14812. (Pubitemid 21907574)
-
(1991)
Journal of Biological Chemistry
, vol.266
, Issue.22
, pp. 14808-14812
-
-
Nolte, C.1
Eigenthaler, M.2
Schanzenbacher, P.3
Walter, U.4
-
31
-
-
0027705097
-
Role of cyclic nucleotidedependent protein kinases and their common substrate VASP in the regulation of human platelets
-
Walter U, Eigenthaler M, Geiger J, et al. Role of cyclic nucleotidedependent protein kinases and their common substrate VASP in the regulation of human platelets. Adv Exp Med Biol. 1993;344:237-249.
-
(1993)
Adv Exp Med Biol
, vol.344
, pp. 237-249
-
-
Walter, U.1
Eigenthaler, M.2
Geiger, J.3
-
32
-
-
0345687479
-
Ena/VASP Proteins: Regulators of the Actin Cytoskeleton and Cell Migration
-
DOI 10.1146/annurev.cellbio.19.050103.103356
-
Krause M, Dent EW, Bear JE, et al. Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu Rev Cell Dev Biol. 2003;19: 541-564. (Pubitemid 37487360)
-
(2003)
Annual Review of Cell and Developmental Biology
, vol.19
, pp. 541-564
-
-
Krause, M.1
Dent, E.W.2
Bear, J.E.3
Loureiro, J.J.4
Gertler, F.B.5
-
33
-
-
1842783140
-
The inhibitory mechanism of YC-1, a benzyl indazole, on smooth muscle cell proliferation: An in vitro and in vivo study
-
Wu CH, Chang WC, Chang GY, et al. The inhibitory mechanism of YC-1, a benzyl indazole, on smooth muscle cell proliferation: an in vitro and in vivo study. J Pharmacol Sci. 2004;94:252-260.
-
(2004)
J Pharmacol Sci
, vol.94
, pp. 252-260
-
-
Wu, C.H.1
Chang, W.C.2
Chang, G.Y.3
-
34
-
-
15044363848
-
Stimulation of soluble guanylyl cyclase inhibits mesangial cell proliferation and matrix accumulation in experimental glomerulonephritis
-
DOI 10.1152/ajprenal.00280.2004
-
Hohenstein B, Daniel C, Wagner A, et al. Stimulation of soluble guanylyl cyclase inhibits mesangial cell proliferation and matrix accumulation in experimental glomerulonephritis. Am J Physiol Renal Physiol. 2005;288: F685-F693. (Pubitemid 40381735)
-
(2005)
American Journal of Physiology - Renal Physiology
, vol.288
, Issue.4
-
-
Hohenstein, B.1
Daniel, C.2
Wagner, A.3
Stasch, J.-P.4
Hugo, C.5
-
35
-
-
34250322705
-
Irsogladine maleate potentiates the effects of nitric oxide on activation of cAMP signalling pathways and suppression of mesangial cell mitogenesis
-
DOI 10.1038/sj.bjp.0707255, PII 0707255
-
Yao J, Zhu Y, Sun W, et al. Irsogladine maleate potentiates the effects of nitric oxide on activation of cAMP signalling pathways and suppression of mesangial cell mitogenesis. Br J Pharmacol. 2007;151:457-466. (Pubitemid 46908558)
-
(2007)
British Journal of Pharmacology
, vol.151
, Issue.4
, pp. 457-466
-
-
Yao, J.1
Zhu, Y.2
Sun, W.3
Sawada, N.4
Hiramatsu, N.5
Takeda, M.6
Kitamura, M.7
-
36
-
-
33751163519
-
Soluble guanylyl cyclase activation promotes angiogenesis
-
DOI 10.1124/jpet.106.108878
-
Pyriochou A, Beis D, Koika V, et al. Soluble guanylyl cyclase activation promotes angiogenesis. J Pharm Exp Ther. 2006;319:663-671. (Pubitemid 44776370)
-
(2006)
Journal of Pharmacology and Experimental Therapeutics
, vol.319
, Issue.2
, pp. 663-671
-
-
Pyriochou, A.1
Beis, D.2
Koika, V.3
Potytarchou, C.4
Papadimitriou, E.5
Zhou, Z.6
Papapetropoulos, A.7
-
37
-
-
33847612871
-
The phosphodiesterase 5 inhibitor sildenafil stimulates angiogenesis through a protein kinase G/MAPK pathway
-
DOI 10.1002/jcp.20929
-
Pyriochou A, Zhou Z, Koika V, et al. The phosphodiesterase 5 inhibitor sildenafil stimulates angiogenesis through a protein kinase G/MAPK pathway. J Cell Physiol. 2007;211:197-204. (Pubitemid 46363910)
-
(2007)
Journal of Cellular Physiology
, vol.211
, Issue.1
, pp. 197-204
-
-
Pyriochou, A.1
Zhou, Z.2
Koika, V.3
Petrou, C.4
Cordopatis, P.5
Sessa, W.C.6
Papapetropoulos, A.7
-
38
-
-
36048936625
-
CGMP-dependent and -independent angiogenesis-related properties of nitric oxide
-
DOI 10.1016/j.lfs.2007.09.014, PII S0024320507007151
-
Pyriochou A, Vassilakopoulos T, Zhou Z, et al. cGMP-dependent and - independent angiogenesis-related properties of nitric oxide. Life Sci. 2007; 81:1549-1554. (Pubitemid 350081039)
-
(2007)
Life Sciences
, vol.81
, Issue.21-22
, pp. 1549-1554
-
-
Pyriochou, A.1
Vassilakopoulos, T.2
Zhou, Z.3
Papapetropoulos, A.4
-
39
-
-
23044472079
-
BAY 41-2272 5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b] pyridine-4-ylamine]- Induced dilation in ovine pulmonary artery: Role of sodium pump
-
Bawankule DU, Sathishkumar K, Sardar KK, et al. BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-4-ylamine]- induced dilation in ovine pulmonary artery: role of sodium pump. J Pharmacol Exp Ther. 2005;314:207-213.
-
(2005)
J Pharmacol Exp Ther
, vol.314
, pp. 207-213
-
-
Bawankule, D.U.1
Sathishkumar, K.2
Sardar, K.K.3
-
40
-
-
34548405655
-
1 subunit in vascular smooth muscle relaxation
-
DOI 10.1016/j.cardiores.2007.06.002, PII S0008636307002805
-
Nimmegeers S, Sips P, Buys E, et al. Functional role of the soluble guanylyl cyclase a1 subunit in vascular smooth muscle relaxation. Cardiovasc Res. 2007;76:149-159. (Pubitemid 47362046)
-
(2007)
Cardiovascular Research
, vol.76
, Issue.1
, pp. 149-159
-
-
Nimmegeers, S.1
Sips, P.2
Buys, E.3
Brouckaert, P.4
Van De Voorde, J.5
-
41
-
-
33644981623
-
Vasorelaxing effect of BAY 41-2272 in rat basilar artery: Involvement of cGMP-dependent and independent mechanisms
-
Teixeira CE, Priviero FBM, Todd JT Jr, et al. Vasorelaxing effect of BAY 41-2272 in rat basilar artery: involvement of cGMP-dependent and independent mechanisms. Hypertension. 2006;47:596-602.
-
(2006)
Hypertension
, vol.47
, pp. 596-602
-
-
Teixeira, C.E.1
Priviero, F.B.M.2
Todd Jr., J.T.3
-
42
-
-
34249033025
-
Effects of BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, on human NADPH oxidase system from THP-1 cells
-
DOI 10.1016/j.ejphar.2007.04.018, PII S0014299907004864
-
de Oliviera-Junior EB, Thomazzi SM, Rehder J, et al. Effects of BAY 41- 2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, on human NADPH oxidase system from THP-1 cells. Eur J Pharmacol. 2007;567:43-49. (Pubitemid 46782833)
-
(2007)
European Journal of Pharmacology
, vol.567
, Issue.1-2
, pp. 43-49
-
-
Borges De Oliveira-Junior, E.1
Thomazzi, S.M.2
Rehder, J.3
Antunes, E.4
Condino-Neto, A.5
-
43
-
-
1842863225
-
High and Low Gain Switches for Regulation of cAMP Efflux Concentration: Distinct Roles for Particulate GC- And Soluble GC-cGMP-PDE3 Signaling in Rabbit Atria
-
DOI 10.1161/01.RES.0000123826.70125.4D
-
Wen JF, Cui X, Jin JY, et al. High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particular GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria. Circ Res. 2004;94:936-943. (Pubitemid 38490071)
-
(2004)
Circulation Research
, vol.94
, Issue.7
, pp. 936-943
-
-
Wen, J.F.1
Cui, X.2
Jin, J.Y.3
Kim, S.M.4
Kim, S.Z.5
Kim, S.H.6
Lee, H.S.7
Cho, K.W.8
-
44
-
-
58849157968
-
YC-1 stimulates the expression of gaseous monoxide-generating enzymes in vascular smooth muscle cells
-
Liu XM, Peyton KJ, Mendelev NN, et al. YC-1 stimulates the expression of gaseous monoxide-generating enzymes in vascular smooth muscle cells. Mol Pharmacol. 2009;75:1-10.
-
(2009)
Mol Pharmacol
, vol.75
, pp. 1-10
-
-
Liu, X.M.1
Peyton, K.J.2
Mendelev, N.N.3
-
45
-
-
0027986509
-
Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP
-
Cornwell TL, Arnold E, Boerth NJ, et al. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol. 1994;267:C1405-C1413. (Pubitemid 2163839)
-
(1994)
AM.J.PHYSIOL.
, vol.267
, Issue.5 PART 1
-
-
Cornwell, T.L.1
Arnold, E.2
Boerth, N.J.3
Lincoln, T.M.4
-
46
-
-
0031876627
-
Cyclic nucleotide crosstalk and the regulation of cerebral vasodilation
-
DOI 10.1016/S0301-0082(98)00009-4, PII S0301008298000094
-
Pelligrino DA, Wang Q. Cyclic nucleotide crosstalk and the regulation of cerebral vasodilation. Prog Neurobiol. 1998;56:1-18. (Pubitemid 28351159)
-
(1998)
Progress in Neurobiology
, vol.56
, Issue.1
, pp. 1-18
-
-
Pelligrino, D.A.1
Wang, Q.2
-
47
-
-
0346366927
-
Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMPindependent but cAMP-dependent pathway
-
Hwang TL, Jung HW, Kao SH, et al. Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMPindependent but cAMP-dependent pathway. Mol Pharmacol. 2003;64: 1419-1427.
-
(2003)
Mol Pharmacol
, vol.64
, pp. 1419-1427
-
-
Hwang, T.L.1
Jung, H.W.2
Kao, S.H.3
-
48
-
-
0033609090
-
Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle
-
Gallo R, Padurean A, Jayaraman T, et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation. 1999;99:2164-2170. (Pubitemid 29196802)
-
(1999)
Circulation
, vol.99
, Issue.16
, pp. 2164-2170
-
-
Gallo, R.1
Padurean, A.2
Jayaraman, T.3
Marx, S.4
Roque, M.5
Adelman, S.6
Chesebro, J.7
Fallon, J.8
Fuster, V.9
Marks, A.10
Badimon, J.J.11
-
49
-
-
0033607695
-
Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: CGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation
-
Fukumoto S, Koyama H, Hosoi M, et al. Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation. Circ Res. 1999;85:985-991.
-
(1999)
Circ Res
, vol.85
, pp. 985-991
-
-
Fukumoto, S.1
Koyama, H.2
Hosoi, M.3
-
50
-
-
33745050483
-
Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation
-
DOI 10.1126/science.1121513, PII 0000301220060512000009
-
Yih-Jer W, Bond M, Sala-Newby GB, et al. Altered S-phase kinaseassociated protein-2 levels are a major mediator of cyclic nucleotideinduced inhibition of vascular smooth muscle cell proliferation. Circ Res. 2006;98:1141-1150. (Pubitemid 43948100)
-
(2006)
Circulation Research
, vol.98
, Issue.9
, pp. 1141-1150
-
-
Wu, Y.-J.1
Bond, M.2
Sala-Newby, G.B.3
Newby, A.C.4
|